Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's Disease - BeatPark Study

Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02438124

Acronym

BeatPark

Enrollment

Registered

2015-05-08

Start date

2014-09-30

Completion date

2016-09-30

Last updated

2016-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, Rhythmic auditory stimulation, Gait

Brief summary

The beneficial effects of rhythmical auditory stimulation (RAS) on spatio-temporal gait characteristics in Parkinson's disease (PD) are attested by clinical research. Nonetheless, it is still unclear which auditory information parameters (i.e. complexity, temporal regularity or adaptability to gait) maximize the effectiveness of RAS. Objectives: To evaluate the beneficial effects of RAS on spatio-temporal gait characteristics in PD patients with gait disorders according to: * RAS complexity (i.e. metronome, amplitude modulated noise, music) * RAS variability (i.e fixed, random, semi-random) * RAS adapted in real-time to gait Variability study: To study the impact of RAS variability (i.e fixed, random, semi-random) in 20 PD patients and 20 healthy controls on spatio-temporal gait characteristics with metronome, amplitude noise and music. Adaptability studyTo study the impact of RAS adaptability (i.e fixed, random, adapted in real-time to gait) in 20 PD patients and 20 healthy controls on spatio-temporal gait characteristics with metronome, amplitude noise and music.

Interventions

BEHAVIORALNeuropsychological evaluation

The subjects are submitted in one hearing stimulus while they realize a walking test

Study design

Allocation

NON_RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* 18 y.o. * to be able to understand the study aims and to agree to participate * to have signed the consent form * to be registered to social security system * to reach the diagnosis criteria of idiopathic PD (Queen Square Brain Bank) * gait disorder clinically observable

Exclusion criteria

* pregnant or lactating woman * high probability of non-compliance * curators , authorship or advisers to person of full age Specific

Design outcomes

Primary

Measure	Time frame	Description
gait velocity	2 days	evaluation of walking speed between the different conditions

Secondary

Measure	Time frame	Description
spatio-temporal gait characteristics	2 days	evaluation of other walking parameters between the different conditions

Countries

France

Contacts

Primary ContactValérie Cochen De Cock, MD

valerie.cochen@gmail.com06 09 04 35 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026